Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, Mar 1997, 142-146, Vol 4, No. 2
L Polonelli, N Seguy, S Conti, M Gerloni, D Bertolotti, C Cantelli, W Magliani and JC Cailliez
Rat monoclonal yeast killer toxin (KT)-like immunoglobulin M (IgM) anti-
idiotypic antibodies (KT-IdAbs) were produced by idiotypic vaccination with
a mouse monoclonal antibody (MAb; MAb KT4) that neutralized a Pichia
anomala KT characterized by a wide spectrum of antimicrobial activity. The
characteristics of the KT-IdAbs were demonstrated by their capacity to
compete with the KT to the idiotype of MAb KT4 and to interact with
putative KT cell wall receptors (KTRs) of sensitive Candida albicans cells.
The internal-image properties of KT-IdAbs were proven by their killer
activity against KT-sensitive yeasts. This lethal effect was abolished by
prior adsorption of KT-IdAbs with MAb KT4. These findings stressed the
potential importance of antibody- mediated immunoprotection against
candidiasis and suggested a feasible experimental approach for producing
antimicrobial receptor antibodies without purifying the receptor. KT-IdAbs
might represent the basis for producing engineered derivatives with a high
potential for effective therapeutic antifungal activity.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies
Istituto di Microbiologia, Facolta di Medicina e Chirurgia, Universita degli Studi di Parma, Italy. lucpol@ipruniv.cce.unipr.it
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |